

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in managing brain metastasis | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1772/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1772" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in managing brain metastasis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in managing brain metastasis.">
            <meta name="og:description" content="Read the latest article version by Rupesh Kotecha, Vinai Gondi, Manmeet S Ahluwalia, Priscilla K Brastianos, Minesh P Mehta, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17362">
            <meta name="article-id" content="15903">
            <meta name="dc.title" content="Recent advances in managing brain metastasis">
            <meta name="dc.description" content="Brain metastases are the most common malignancy encountered in the central nervous system (CNS), with up to 30-40% of cancer patients developing brain metastases at some point during the course of their disease. The management of brain metastasis is rapidly evolving and the roles of local therapies such as whole-brain radiation therapy, stereotactic radiosurgery, and resection along with systemic therapies are in flux. An emphasis on the neurocognitive side effects associated with treatment has gained prominence. Novel molecular studies have demonstrated important evolutionary patterns underpinning the development of brain metastasis and leptomeningeal disease, which may be key to unlocking new therapeutic strategies. This article provides a framework for incorporating the results of recent randomized radiotherapy clinical trials into practice, expounds upon the emphasis on cognition being an important driver in therapeutic selection, describes the importance of CNS-penetrating systemic therapies, and provides an overview of the novel molecular insights that will likely set the stage for future developments in this field.">
            <meta name="dc.subject" content="brain metastasis, whole brain radiation therapy, stereotactic radiosurgery, neurocognition, targeted therapy, genomic">
            <meta name="dc.creator" content="Kotecha, Rupesh">
            <meta name="dc.creator" content="Gondi, Vinai">
            <meta name="dc.creator" content="Ahluwalia, Manmeet S">
            <meta name="dc.creator" content="Brastianos, Priscilla K">
            <meta name="dc.creator" content="Mehta, Minesh P">
            <meta name="dc.date" content="2018/11/09">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.15903.1">
            <meta name="dc.source" content="F1000Research 2018 7:1772">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="brain metastasis">
            <meta name="prism.keyword" content="whole brain radiation therapy">
            <meta name="prism.keyword" content="stereotactic radiosurgery">
            <meta name="prism.keyword" content="neurocognition">
            <meta name="prism.keyword" content="targeted therapy">
            <meta name="prism.keyword" content="genomic">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/11/09">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1772">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.15903.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1772">
            <meta name="citation_title" content="Recent advances in managing brain metastasis">
            <meta name="citation_abstract" content="Brain metastases are the most common malignancy encountered in the central nervous system (CNS), with up to 30-40% of cancer patients developing brain metastases at some point during the course of their disease. The management of brain metastasis is rapidly evolving and the roles of local therapies such as whole-brain radiation therapy, stereotactic radiosurgery, and resection along with systemic therapies are in flux. An emphasis on the neurocognitive side effects associated with treatment has gained prominence. Novel molecular studies have demonstrated important evolutionary patterns underpinning the development of brain metastasis and leptomeningeal disease, which may be key to unlocking new therapeutic strategies. This article provides a framework for incorporating the results of recent randomized radiotherapy clinical trials into practice, expounds upon the emphasis on cognition being an important driver in therapeutic selection, describes the importance of CNS-penetrating systemic therapies, and provides an overview of the novel molecular insights that will likely set the stage for future developments in this field.">
            <meta name="citation_description" content="Brain metastases are the most common malignancy encountered in the central nervous system (CNS), with up to 30-40% of cancer patients developing brain metastases at some point during the course of their disease. The management of brain metastasis is rapidly evolving and the roles of local therapies such as whole-brain radiation therapy, stereotactic radiosurgery, and resection along with systemic therapies are in flux. An emphasis on the neurocognitive side effects associated with treatment has gained prominence. Novel molecular studies have demonstrated important evolutionary patterns underpinning the development of brain metastasis and leptomeningeal disease, which may be key to unlocking new therapeutic strategies. This article provides a framework for incorporating the results of recent randomized radiotherapy clinical trials into practice, expounds upon the emphasis on cognition being an important driver in therapeutic selection, describes the importance of CNS-penetrating systemic therapies, and provides an overview of the novel molecular insights that will likely set the stage for future developments in this field.">
            <meta name="citation_keywords" content="brain metastasis, whole brain radiation therapy, stereotactic radiosurgery, neurocognition, targeted therapy, genomic">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Rupesh Kotecha">
            <meta name="citation_author_institution" content="Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA">
            <meta name="citation_author_institution" content="Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA">
            <meta name="citation_author" content="Vinai Gondi">
            <meta name="citation_author_institution" content="Northwestern Medicine Cancer Center Warrenville, Warrenville, IL, USA">
            <meta name="citation_author_institution" content="Northwestern University Feinberg School of Medicine, Chicago, IL, USA">
            <meta name="citation_author" content="Manmeet S Ahluwalia">
            <meta name="citation_author_institution" content="Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA">
            <meta name="citation_author_institution" content="Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA">
            <meta name="citation_author" content="Priscilla K Brastianos">
            <meta name="citation_author_institution" content="Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA">
            <meta name="citation_author_institution" content="Harvard Medical School, Boston, MA, USA">
            <meta name="citation_author" content="Minesh P Mehta">
            <meta name="citation_author_institution" content="Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA">
            <meta name="citation_author_institution" content="Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA">
            <meta name="citation_publication_date" content="2018/11/09">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1772">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.15903.1">
            <meta name="citation_firstpage" content="1772">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1772/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1772.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17362 /> <input type=hidden id=articleId name=articleId value=15903 /> <input type=hidden id=xmlUrl value="/articles/7-1772/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1772-v1.xml"> <input type=hidden id=article_uuid value=34777412-2e6a-4922-bda0-d4273962298d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in managing brain metastasis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.15903.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.15903.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1772"
  },
  "headline": "Recent advances in managing brain metastasis",
  "datePublished": "2018-11-09T16:52:48",
  "dateModified": "2018-11-09T16:52:48",
  "author": [
    {
      "@type": "Person",
      "name": "Rupesh Kotecha"
    },    {
      "@type": "Person",
      "name": "Vinai Gondi"
    },    {
      "@type": "Person",
      "name": "Manmeet S Ahluwalia"
    },    {
      "@type": "Person",
      "name": "Priscilla K Brastianos"
    },    {
      "@type": "Person",
      "name": "Minesh P Mehta"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Brain metastases are the most common malignancy encountered in the central nervous system (CNS), with up to 30-40% of cancer patients developing brain metastases at some point during the course of their disease. The management of brain metastasis is rapidly evolving and the roles of local therapies such as whole-brain radiation therapy, stereotactic radiosurgery, and resection along with systemic therapies are in flux. An emphasis on the neurocognitive side effects associated with treatment has gained prominence. Novel molecular studies have demonstrated important evolutionary patterns underpinning the development of brain metastasis and leptomeningeal disease, which may be key to unlocking new therapeutic strategies. This article provides a framework for incorporating the results of recent randomized radiotherapy clinical trials into practice, expounds upon the emphasis on cognition being an important driver in therapeutic selection, describes the importance of CNS-penetrating systemic therapies, and provides an overview of the novel molecular insights that will likely set the stage for future developments in this field."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1772/v1",
            "name": "Recent advances in managing brain metastasis"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in managing brain metastasis </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17362 data-id=15903 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15903.1" data-recommended="" data-doi="10.12688/f1000research.15903.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1772/v1/pdf?article_uuid=34777412-2e6a-4922-bda0-d4273962298d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-15903-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-15903-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-15903-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Kotecha R, Gondi V, Ahluwalia MS <em>et al.</em> Recent advances in managing brain metastasis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1772 (<a class=new-orange href="https://doi.org/10.12688/f1000research.15903.1" target=_blank>https://doi.org/10.12688/f1000research.15903.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-15903-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=15903 id=track-article-signin-15903 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15903?target=/articles/7-1772/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17362 /> <input name=articleId type=hidden value=15903 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in managing brain metastasis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Rupesh Kotecha<sup>1,2</sup>,&nbsp;</span><span class="">Vinai Gondi<sup>3,4</sup>,&nbsp;</span><span class="">Manmeet S Ahluwalia<sup>5,6</sup>,&nbsp;</span><span class="">Priscilla K Brastianos<sup>7,8</sup>,&nbsp;</span><span class=""><a href="mailto:mmehta@nmff.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Minesh P Mehta</span></a><a href="https://orcid.org/0000-0002-4812-5713" target=_blank id=author-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4812-5713</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Rupesh Kotecha<sup>1,2</sup>,&nbsp;</span><span class="">Vinai Gondi<sup>3,4</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Manmeet S Ahluwalia<sup>5,6</sup>,&nbsp;</span><span class="">Priscilla K Brastianos<sup>7,8</sup>,&nbsp;</span><span class=""><a href="mailto:mmehta@nmff.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Minesh P Mehta</span></a><a href="http://orcid.org/0000-0002-4812-5713" target=_blank id=mauthor-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4812-5713</div><sup>1,2</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 09 Nov 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.15903.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA<br/> <sup>2</sup> Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA<br/> <sup>3</sup> Northwestern Medicine Cancer Center Warrenville, Warrenville, IL, USA<br/> <sup>4</sup> Northwestern University Feinberg School of Medicine, Chicago, IL, USA<br/> <sup>5</sup> Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA<br/> <sup>6</sup> Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA<br/> <sup>7</sup> Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA<br/> <sup>8</sup> Harvard Medical School, Boston, MA, USA<br/> <p> <div class=margin-bottom> Rupesh Kotecha <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Vinai Gondi <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Manmeet S Ahluwalia <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Priscilla K Brastianos <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Minesh P Mehta <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41291-40180></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=41290-40181></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Brain metastases are the most common malignancy encountered in the central nervous system (CNS), with up to 30-40% of cancer patients developing brain metastases at some point during the course of their disease. The management of brain metastasis is rapidly evolving and the roles of local therapies such as whole-brain radiation therapy, stereotactic radiosurgery, and resection along with systemic therapies are in flux. An emphasis on the neurocognitive side effects associated with treatment has gained prominence. Novel molecular studies have demonstrated important evolutionary patterns underpinning the development of brain metastasis and leptomeningeal disease, which may be key to unlocking new therapeutic strategies. This article provides a framework for incorporating the results of recent randomized radiotherapy clinical trials into practice, expounds upon the emphasis on cognition being an important driver in therapeutic selection, describes the importance of CNS-penetrating systemic therapies, and provides an overview of the novel molecular insights that will likely set the stage for future developments in this field. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> brain metastasis, whole brain radiation therapy, stereotactic radiosurgery, neurocognition, targeted therapy, genomic </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Minesh P Mehta (<a href="mailto:mmehta@nmff.org">mmehta@nmff.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Minesh P Mehta </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Kotecha R <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Kotecha R, Gondi V, Ahluwalia MS <em>et al.</em> Recent advances in managing brain metastasis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1772 (<a href="https://doi.org/10.12688/f1000research.15903.1" target=_blank>https://doi.org/10.12688/f1000research.15903.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 09 Nov 2018, <b>7</b>(F1000 Faculty Rev):1772 (<a href="https://doi.org/10.12688/f1000research.15903.1" target=_blank>https://doi.org/10.12688/f1000research.15903.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 09 Nov 2018, <b>7</b>(F1000 Faculty Rev):1772 (<a href="https://doi.org/10.12688/f1000research.15903.1" target=_blank>https://doi.org/10.12688/f1000research.15903.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d92168e256>Introduction</h2><p class="" id=d92168e259>Brain metastases are the most common malignancy encountered in the central nervous system (CNS). Conventional therapeutic options have included resection, whole brain radiotherapy (WBRT), and stereotactic radiosurgery (SRS), with a very limited historical role for chemotherapy. However, targeted agents with blood-brain barrier (BBB)-penetrating capabilities, as well as immune checkpoint inhibitors (ICI) are expanding the role of systemic therapies in select subsets of patients, and current research focuses on identifying the best combinatorial approaches. WBRT has served as a component of treatment for several decades, but its role is rapidly evolving. It has proven beneficial in symptomatic patients for palliative relief, as primary treatment for brain metastases in patients who are expected to experience longer-term survival and in whom other treatments are not possible, as adjuvant therapy to lower recurrence rates after either resection or SRS, and as prophylactic treatment for systemic cancers that have a greater likelihood of intracranial spread. The cognitive toxicity of WBRT, however, cannot be ignored as the long-term sequelae can significantly impact quality of life; approaches that minimize this will be reviewed. SRS has been ascendant because of a lower cognitive dysfunction profile, and we shall review current clinical trials redefining the roles of these therapies. With the advent of targeted and immunological agents, the therapeutic landscape is shifting once again, and, as we shall demonstrate, novel molecular insights will most likely set the stage for revolutionary future advances.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d92168e265>Overview of recent randomized radiotherapy clinical trials</h2><p class="" id=d92168e268>Although WBRT is one of the standard treatment options for patients with brain metastasis, until recently, only one trial had compared the efficacy of WBRT vs. medical management. In 1971, the Eastern Cooperative Oncology Group (ECOG) reported on a study of 48 patients with brain metastases randomized to prednisone with or without WBRT<sup><a href="#ref-1">1</a></sup>. Clinical criteria were used to assess improvement in the patients’ status. WBRT prolonged both the duration of clinical remission (11 vs. 5 weeks, statistically significant, a relative improvement of 120%) and overall survival (median 14 vs. 10 weeks, relative improvement of 40%, but <i>P</i> = ns, underpowered to detect a survival benefit).</p><p class="" id=d92168e278>The value of WBRT was re-examined in the Medical Research Council (MRC) QUARTZ trial. In this study, 538 patients with non-small cell lung cancer (NSCLC) with brain metastasis unsuitable for surgery or SRS and in whom there was “uncertainty in the clinicians’ or patients’ minds about the potential benefit of WBRT” were randomized to dexamethasone and WBRT (20 Gy/5 fractions) versus dexamethasone and supportive care alone<sup><a href="#ref-2">2</a></sup>. This trial reported no difference in quality adjusted life days (46.4 with WBRT vs. 41.7 with supportive care; the measure of quality included dexamethasone-induced issues, and dexamethasone was used in both arms) - the primary endpoint of the study - and only a five day difference in median survival<sup><a href="#ref-2">2</a></sup>. What should practitioners take away from this trial? Quite simply, in patients with brain metastasis with a very short expected survival (similar to the poor outcomes observed in patients treated before the 1970s), hospice care and supportive management alone is appropriate.</p><p class="" id=d92168e289>The role of radiation therapy after surgery for patients with brain metastasis has been evaluated in randomized trials. The Patchell study, published 20 years ago, demonstrated that, in patients with a single brain metastasis, WBRT after surgery reduced the rate of surgical bed and distant brain relapse, and neurologic death<sup><a href="#ref-3">3</a></sup>. In the more recent MD Anderson Cancer Center (MDACC) study, patients who underwent resection of brain metastasis were randomized to observation or SRS. SRS improved the 12-month rate of local control (72% vs. 45%) and median time to local recurrence (not reached vs. 7.6 months) but SRS neither reduced the rate of distant brain failure nor did it improve overall survival<sup><a href="#ref-4">4</a></sup>. One important finding was the poor local control (&lt;50% at 12-months) observed in lesions &gt;2.5 cm, underscoring the need to improve outcomes through improved resection cavity delineation, dose-escalation, fractionated radiosurgery, or use of pre-op SRS<sup><a href="#ref-5">5</a></sup>. Although this trial supports the use of SRS after surgery, physicians need to caution patients about the significant risks of distant brain and/or leptomeningeal failure in the setting of focal therapy alone<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d92168e308>In the EORTC trial, after local therapy (SRS or surgery) patients were randomized to observation or WBRT. WBRT significantly reduced intracranial relapse (both local and distant) as well as neurologic death, but without prolonging overall survival<sup><a href="#ref-7">7</a></sup>. To explore SRS as an alternative to WBRT, the N107C trial compared these two modalities. Patients undergoing resection of a brain metastasis were randomized to WBRT or SRS to the resection cavity with SRS allowed to other intact metastases. The primary endpoint, cognitive deterioration-free survival, was judged to be a single standard deviation reduction in any single cognitive domain. Although there was a two week benefit in cognitive preservation in the SRS arm compared to the WBRT arm (approximately the time needed to deliver WBRT), more striking was the six-month rate of cognitive deterioration in both arms (85% for WBRT and 52% for SRS, a rather high rate of cognitive decline, not previously well-described as a consequence of SRS)<sup><a href="#ref-8">8</a></sup>. The rate of surgical bed control was higher in patients who received WBRT (78% vs. 57%) as was overall brain control (70% vs. 32%). Therefore, SRS is a reasonable option for patients after surgery, but patients should be appropriately counseled about the high rates of neurocognitive decline after SRS (especially because SRS is frequently presented as modality with negligible cognitive deficits), as well as the enhanced risks of local and distant brain failure, without a survival advantage over any modality.</p><p class="" id=d92168e320>Two randomized trials had previously evaluated the role of WBRT in addition to SRS for patients with limited brain metastases. The benefit of WBRT in reducing local relapse (27–33% without WBRT vs. 11–19% with WBRT) as well as distant brain failure (48–64% without WBRT vs. 27–42% with WBRT) was observed in both<sup><a href="#ref-7">7</a>,<a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>. The N0574 study re-examined this question by randomizing patients with 1–3 brain metastases to SRS with or without WBRT. Consistent with previous studies, this trial also demonstrated benefits of WBRT in reducing local failure (27 vs. 10%) and distant brain failure (30% vs. 8%)<sup><a href="#ref-11">11</a></sup>. However, there was improvement in the rate of cognitive deterioration (64% vs. 92% at 3 months) as well as improvement in quality-of-life in patients treated with SRS alone. Therefore, primary SRS is a reasonable option for patients with limited brain metastases, albeit with only modest impact on neurocognition and quality-of-life. In practice, we should carefully select the patients who receive each of these modalities and identifying patients at high risk for neurologic death or intracranial failure may help further inform these decisions<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d92168e341>The aforementioned trials have clarified the role of WBRT in patients with poor expected survival, validated the need for adjuvant radiotherapy after surgery for brain metastasis, demonstrated the advantages and limitations of SRS after surgery in comparison to WBRT, and supported the role of single modality focal therapy in patients with limited brain metastases, as long as the substantially enhanced risk of intracranial failure is acceptable to the patient.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d92168e347>Cognition as a key driver in therapeutic selection</h2><p class="" id=d92168e350>Surveys of brain metastasis patients and oncology nurses reveal cognition as an important factor in patient preferences for treatment<sup><a href="#ref-13">13</a></sup>. Several randomized trials have demonstrated cognitive decline following WBRT, with cognitive function measured using a validated, multi-dimensional battery of tests assessing episodic memory (HVLT-R), executive function (TMT Part B, COWA), processing speed (TMT Part A), and fine motor control (Grooved Pegboard)<sup><a href="#ref-8">8</a>,<a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. These studies have observed an improvement in the rate of 3-standard deviation decline of cognitive testing from baseline to 3-6 months post-treatment from 35–52% in WBRT vs. 6–24% after SRS<sup><a href="#ref-8">8</a>,<a href="#ref-11">11</a></sup>. Interestingly, a significant proportion of the cognitive difference between WBRT and SRS seems to selectively involve decline in HVLT-R, implying a differential sensitivity of episodic memory to WBRT. </p><p class="" id=d92168e374>However, demonstration of these cognitive effects has important limitations. Since most studies use a time-to-event analysis, these trials are limited in their capacity to assess for later recovery, following initial decline in cognitive function. However, since many brain metastasis patients on these trials did not live beyond six months, the relevance of such longer-term follow-up can be questioned. In addition, while trials have demonstrated cognitive and quality-of-life effects following WBRT, one study observed decline in episodic memory in addition to self-reported cognitive complaints; however, minimal correlation was seen between decline in tested versus patient-reported cognitive function<sup><a href="#ref-14">14</a></sup>. Such discordance between objectively measured and patient-reported cognitive function has been seen in other cognitive disorders such as Alzheimer’s dementia, and highlights the need to objectively measure cognition with performance-based neuropsychological tests along with patient-reported outcomes<sup><a href="#ref-15">15</a></sup>. Alternatively, it could also provide the almost heretical conclusion that patients care less about cognitive test scores and focus more on daily life activity issues that these tests do not measure, a very sobering thought!</p><p class="" id=d92168e385>In a small minority of patients (less than 5%), WBRT can be associated with debilitating dementia, which represents the more severe end of the spectrum of cognitive decline reported in clinical trials<sup><a href="#ref-16">16</a></sup>. This severe form of radiation-induced toxicity can manifest as progressive dementia, gait ataxia and urinary incontinence – especially in patients treated with hypofractionated schedules (&gt;3.5 Gy/fraction)<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d92168e396>Over the past decade, there have been significant advances in the development and testing of pharmacologic and technologic approaches for reducing cognitive decline following WBRT. Memantine is a non-competitive, low-affinity, open-channel antagonist of the N-methyl-D-aspartate (NMDA) receptor that blocks pathologically excessive stimulation of NMDA receptors. In pre-clinical models, memantine has been shown to be neuro-protective and in two placebo-controlled trials it proved to be an effective treatment for vascular dementia<sup><a href="#ref-17">17</a>–<a href="#ref-20">20</a></sup>. RTOG 0614 randomized 554 patients with brain metastases receiving WBRT to either memantine or placebo<sup><a href="#ref-21">21</a></sup>. Although this study did not meet its pre-defined endpoint, multiple other endpoints were either clinically or statistically significant. For example, patients who were randomized to the memantine arm experienced a longer time to cognitive decline as well as a reduced risk for cognitive failure following treatment (54% vs. 65%, <i>P</i> = 0.01). Furthermore, memantine was neuroprotective in multiple cognitive domains including executive function, processing speed, and delayed recognition.</p><p class="" id=d92168e414>Recently, conformal avoidance of the neural stem-cell bearing subgranular zone of the hippocampal dentate gyrus using intensity-modulated radiotherapy (IMRT) during WBRT has shown significant promise in preventing cognitive toxicity from WBRT. The production of new neurons from mitotically active neural stem cells found in the subgranular zone of the hippocampal dentate gyrus is key to the creation of new memories<sup><a href="#ref-22">22</a></sup>. The results of preclinical studies show that damage to these neural stem cells from even low doses of radiation underpin radiotherapy-induced cognitive toxicity. Additional clinical studies have established a dose-response relationship between the dose received by the hippocampus and risk of post-radiotherapy decline in episodic memory<sup><a href="#ref-23">23</a></sup>. Modern hippocampal avoidance (HA-WBRT) IMRT techniques have been developed to conformally avoid the hippocampal dentate gyrus while still covering the at-risk brain parenchyma<sup><a href="#ref-14">14</a></sup>. RTOG 0933, a single-arm phase II trial, demonstrated that HA-WBRT was associated with highly promising preservation of memory and quality-of-life, as compared to pre-specified historical controls. Specifically, the primary endpoint on this trial, the mean relative decline in HVLT-R delayed recall score from baseline to four months was only 7%, significantly better in comparison to the 30% decline in the historical control (<i>P</i> &lt;0.001). To validate these findings, NRG CC001 (ClinicalTrials.gov identifier NCT02360215), a phase III, 518-patient trial of WBRT with memantine (M) with or without hippocampal avoidance for patients with brain metastases with the primary outcome of time to neurocognitive failure (NCF) was completed and presented at the ASTRO Annual Meeting in 2018. Time to NCF failure was significantly longer in favor of HA-WBRT+M. The NCF failure rates following WBRT+M vs. HA-WBRT+M were 63.0% vs. 53.7% at four months, and 69.1% vs. 58.0% at six months (<i>P</i> = 0.012).</p><p class="" id=d92168e435>NRG CC003 (ClinicalTrials.gov identifier NCT02635009) is an ongoing randomized phase II/III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small cell lung cancer with the primary outcomes of intracranial relapse rate and six-month deterioration in episodic memory; the randomized phase II component has completed accrual.</p><p class="" id=d92168e438>Prior studies comparing cognitive outcomes following SRS and WBRT have not included these neuroprotective strategies that may reduce cognitive decline following WBRT. Thus, the optimal selection of SRS versus WBRT in the modern era of brain metastasis management remains an area of important investigation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d92168e444>The advent of systemic therapies</h2><p class="" id=d92168e447>Traditional cytotoxic chemotherapy had a limited role in the management of brain metastases due to the presence of the BBB and such therapies were associated with low response rates<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. With the advent of targeted therapies and immunotherapy, the role of medical therapy is experiencing a resurgence. Targeted therapies have mostly been evaluated in subsets of patients with lung cancer, breast cancer, and melanoma. The use of first generation tyrosine kinase inhibitors (TKIs) that act on <i>EGFR</i>-mutant NSCLC brain metastases, such as erlotinib and gefitinib, are associated with response rates of 50–80%, and overall survival of 12–24 months<sup><a href="#ref-26">26</a>–<a href="#ref-28">28</a></sup>. Trials with third generation TKIs such as osimertinib are associated with response rates of 55–70% with more durable responses<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. In the AURA -3 study, osimertinib yielded response rates of 70%<sup><a href="#ref-30">30</a></sup>. Newer agents that target EGFR include AZD-3759<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup> and avitinib (targets the EGFR T790M resistant mutation)<sup><a href="#ref-33">33</a></sup>. In NSCLC brain metastases with <i>ALK</i> translocations, the first generation inhibitor crizotinib resulted in response rates of 18%<sup><a href="#ref-34">34</a></sup>. Newer generation drugs such as alectinib<sup><a href="#ref-35">35</a></sup>, ceritinib<sup><a href="#ref-36">36</a></sup>, and brigatinib<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup> (a combined ALK and EGFR inhibitor) with better ability to cross the BBB<sup><a href="#ref-39">39</a></sup>, have resulted in responses rates of 45–78%.</p><p class="" id=d92168e517>In breast cancer patients with brain metastases, most targeted agents have been evaluated in the HER2-positive setting<sup><a href="#ref-40">40</a></sup>. Lapatinib, a small molecule TKI inhibitor of HER2, has limited activity as a single agent, and has been combined with capecitabine<sup><a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup>. In phase II studies, the lapatinib-capecitabine combination results in response rates of 66% in radiotherapy-naive patients and 20% in radiation refractory patients<sup><a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup>. Neratinib has demonstrated limited efficacy with responses rates of 8% in HER2-positive brain metastases<sup><a href="#ref-44">44</a></sup>; however, response rates improve to 49% with capecitabine<sup><a href="#ref-45">45</a></sup>. Other drugs being examined in this patient population include tucatinib and tesevatinib<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>.</p><p class="" id=d92168e554>Of patients with brain metastases from melanoma, 40–50% harbor BRAF mutations, and the use of the BRAF inhibitor vemurafenib is associated with 18–20% response rates and dabrafenib yields 30–40% response rates<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. Similar to breast cancer patients, higher response rates are seen in patients that are radiation naive. The dabrafenib/trematinib combination is associated with response rates of 55%<sup><a href="#ref-50">50</a></sup>. The duration of response with dabrafenib and trematinib is approximately six months.</p><p class="" id=d92168e568>Immunotherapies represent an exciting area of research in brain metastases. Drugs that target immune surface proteins CTLA4 (ipilimumab) and programmed cell death protein 1 (PD1) (pembrolizumab and nivolumab) have been developed and evaluated in patients with lung cancer and melanoma brain metastases<sup><a href="#ref-51">51</a></sup>. A phase II trial of ipilimumab demonstrated disease control rates of 25% in those who were not on steroids and 10% in patients on steroids<sup><a href="#ref-52">52</a></sup>. Phase II trials of pembrolizumab showed response rates of 22% in melanoma and 33% in NSCLC<sup><a href="#ref-53">53</a></sup>. The combination of ipilimumab and nivolumab is associated with response rates of 45–57% (in some studies, stable disease is included in this measure) in patients with melanoma brain metastases<sup><a href="#ref-54">54</a>–<a href="#ref-56">56</a></sup>. Most of the initial trials evaluated these ICIs or receptor tyrosine kinase inhibitors (RTKIs) alone in brain metastases. A number of retrospective studies have shown that these agents can safely be used with SRS and have shown improved clinical benefit compared to those treated with SRS alone, or ICIs/RTKIs alone<sup><a href="#ref-57">57</a></sup>. A number of ongoing trials are therefore evaluating these agents in combination with WBRT or SRS.</p><p class="" id=d92168e595>With increasing CNS penetration and intracranial efficacy with systemic therapies, a current dilemma in clinical practice is the use of upfront SRS at time of brain metastasis diagnosis or delayed SRS in patients who fail systemic therapies. Retrospective data using a strategy of systemic therapy with delayed SRS are mixed, with some series demonstrating no difference in survival<sup><a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>, while others show a detriment to patient outcome with upfront systemic therapy alone<sup><a href="#ref-60">60</a></sup>. Given the limited data in this setting, a randomized study is clearly needed to determine the optimal sequencing of available therapies.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d92168e612>Novel molecular insights set the stage for the future</h2><p class="" id=d92168e615>Recent advances in genomic technologies and analytic tools have enhanced our understanding of the genetics of brain metastases. Unanswered questions have included whether brain metastases are genetically heterogeneous compared to their primary tumors, and whether differential clinical responses can be explained by such genetic heterogeneity.</p><p class="" id=d92168e618>A massively parallel sequencing study of one matched brain metastasis and a primary breast cancer showed two <i>de novo</i> mutations and a deletion in the metastasis and not in the primary tumor<sup><a href="#ref-61">61</a></sup>. In a comprehensive genomic study of 104 matched brain metastases and primary tumors across multiple histologies and a variety of treatment regimens, investigators mapped out the phylogenetic relationship between brain metastases and primary tumors<sup><a href="#ref-62">62</a></sup>. An evolutionary pattern of ‘branched’ or divergent evolution was ubiquitously observed, meaning the primary tumor and brain metastasis shared a common ancestor, yet there was significant divergent evolution in each site. As a result of this branched evolution pattern, in more than 50% of cases, clinically actionable alterations were present in the brain metastasis, and not detected in the primary tumor. This implies that genomic characterization of the primary tumor alone to identify therapeutic targets may miss potentially clinically significant alterations in the brain metastasis. Notably, when multiple regional and anatomically distinct brain metastases were analyzed, the majority of clinically actionable alterations were shared among the intracranial sites, suggesting genomic homogeneity within the brain itself. Furthermore, extracranial metastases (as opposed to the primary tumor) displayed divergent evolution and were not a genetic surrogate for clinically actionable alterations in the brain metastases. These data suggest that genetic heterogeneity, at least in part, contributes to divergent therapeutic responses within the same patient. This study also demonstrated that alterations in the CDK, PI3K/AKT and HER2/EGFR pathways were common in brain metastases, suggesting that targeting these pathways should be considered. Other investigations have confirmed an enrichment of the PI3K/PTEN pathway in brain metastases when compared to extracranial sites in melanoma<sup><a href="#ref-63">63</a></sup>, squamous cell lung cancers<sup><a href="#ref-64">64</a></sup> and breast cancer<sup><a href="#ref-65">65</a></sup>. FGFR amplifications are also more enriched in brain metastases from lung adenocarcinomas compared to primary tumors, and also represent a potential therapeutic target for brain metastases patients<sup><a href="#ref-66">66</a></sup>. </p><p class="" id=d92168e649>Clinical trials should be conducted to answer the question of whether targeting the alterations specific to the brain metastasis will lead to improved clinical outcomes. Large-scale molecular studies of brain metastases across multiple histologic tumor types are needed to identify additional therapeutic targets. Nevertheless, molecular analysis of brain metastasis tissue, if available as part of clinical care, should be considered to identify potential targeted therapies.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d92168e1 class=n-a></a><h2 class=main-title id=d92385>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i></p></div><div class=back-section><a name=d92168e656 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d92595>References</h2><div class="section ref-list"><a name=d92168e656 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d92168e663 class=n-a></a>Horton J, Baxter DH, Olson KB: The management of metastases to the brain by irradiation and corticosteroids. <i>Am J Roentgenol Radium Ther Nucl Med.</i> 1971; <b>111</b>(2): 334–6. <a target=xrefwindow id=d92168e671 href="http://www.ncbi.nlm.nih.gov/pubmed/5541678">PubMed Abstract </a> | <a target=xrefwindow id=d92168e674 href="https://doi.org/10.2214/ajr.111.2.334">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726720378"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e683 class=n-a></a>Mulvenna P, Nankivell M, Barton R, <i> et al.</i>: Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): Results from a phase 3, non-inferiority, randomised trial. <i>Lancet.</i> 2016; <b>388</b>(10055): 2004–14. <a target=xrefwindow id=d92168e694 href="http://www.ncbi.nlm.nih.gov/pubmed/27604504">PubMed Abstract </a> | <a target=xrefwindow id=d92168e697 href="https://doi.org/10.1016/S0140-6736(16)30825-X">Publisher Full Text </a> | <a target=xrefwindow id=d92168e701 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5082599">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726720378">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d92168e714 class=n-a></a>Patchell RA, Tibbs PA, Regine WF, <i> et al.</i>: Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. <i>JAMA.</i> 1998; <b>280</b>(17): 1485–9. <a target=xrefwindow id=d92168e725 href="http://www.ncbi.nlm.nih.gov/pubmed/9809728">PubMed Abstract </a> | <a target=xrefwindow id=d92168e728 href="https://doi.org/10.1001/jama.280.17.1485">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727788113"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e737 class=n-a></a>Mahajan A, Ahmed S, McAleer MF, <i> et al.</i>: Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: A single-centre, randomised, controlled, phase 3 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(8): 1040–8. <a target=xrefwindow id=d92168e748 href="http://www.ncbi.nlm.nih.gov/pubmed/28687375">PubMed Abstract </a> | <a target=xrefwindow id=d92168e751 href="https://doi.org/10.1016/S1470-2045(17)30414-X ">Publisher Full Text </a> | <a target=xrefwindow id=d92168e755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5560102">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727788113">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731935903"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e768 class=n-a></a>Soliman H, Ruschin M, Angelov L, <i> et al.</i>: Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. <i>Int J Radiat Oncol Biol Phys.</i> 2018; <b>100</b>(2): 436–42. <a target=xrefwindow id=d92168e779 href="http://www.ncbi.nlm.nih.gov/pubmed/29157748">PubMed Abstract </a> | <a target=xrefwindow id=d92168e782 href="https://doi.org/10.1016/j.ijrobp.2017.09.047">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731935903">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718119374"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e796 class=n-a></a>Atalar B, Modlin LA, Choi CY, <i> et al.</i>: Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. <i>Int J Radiat Oncol Biol Phys.</i> 2013; <b>87</b>(4): 713–8. <a target=xrefwindow id=d92168e807 href="http://www.ncbi.nlm.nih.gov/pubmed/24054875">PubMed Abstract </a> | <a target=xrefwindow id=d92168e810 href="https://doi.org/10.1016/j.ijrobp.2013.07.034">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718119374">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/7110958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e823 class=n-a></a>Kocher M, Soffietti R, Abacioglu U, <i> et al.</i>: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study. <i>J Clin Oncol.</i> 2011; <b>29</b>(2): 134–41. <a target=xrefwindow id=d92168e834 href="http://www.ncbi.nlm.nih.gov/pubmed/21041710">PubMed Abstract </a> | <a target=xrefwindow id=d92168e837 href="https://doi.org/10.1200/JCO.2010.30.1655">Publisher Full Text </a> | <a target=xrefwindow id=d92168e841 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3058272">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/7110958">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727788111"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e854 class=n-a></a>Brown PD, Ballman KV, Cerhan JH, <i> et al.</i>: Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(8): 1049–60. <a target=xrefwindow id=d92168e865 href="http://www.ncbi.nlm.nih.gov/pubmed/28687377">PubMed Abstract </a> | <a target=xrefwindow id=d92168e868 href="https://doi.org/10.1016/S1470-2045(17)30441-2">Publisher Full Text </a> | <a target=xrefwindow id=d92168e872 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5568757">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727788111">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e885 class=n-a></a>Aoyama H, Shirato H, Tago M, <i> et al.</i>: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. <i>JAMA.</i> 2006; <b>295</b>(21): 2483–91. <a target=xrefwindow id=d92168e896 href="http://www.ncbi.nlm.nih.gov/pubmed/16757720">PubMed Abstract </a> | <a target=xrefwindow id=d92168e899 href="https://doi.org/10.1001/jama.295.21.2483">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14371">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1166472"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e912 class=n-a></a>Chang EL, Wefel JS, Hess KR, <i> et al.</i>: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. <i>Lancet Oncol.</i> 2009; <b>10</b>(11): 1037–44. <a target=xrefwindow id=d92168e923 href="http://www.ncbi.nlm.nih.gov/pubmed/19801201">PubMed Abstract </a> | <a target=xrefwindow id=d92168e926 href="https://doi.org/10.1016/S1470-2045(09)70263-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1166472">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726578790"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e939 class=n-a></a>Brown PD, Jaeckle K, Ballman KV, <i> et al.</i>: Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>316</b>(4): 401–9. <a target=xrefwindow id=d92168e950 href="http://www.ncbi.nlm.nih.gov/pubmed/27458945">PubMed Abstract </a> | <a target=xrefwindow id=d92168e953 href="https://doi.org/10.1001/jama.2016.9839">Publisher Full Text </a> | <a target=xrefwindow id=d92168e957 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5313044">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726578790">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d92168e971 class=n-a></a>McTyre E, Ayala-Peacock D, Contessa J, <i> et al.</i>: Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis. <i>Ann Oncol.</i> 2018; <b>29</b>(2): 497–503. <a target=xrefwindow id=d92168e982 href="http://www.ncbi.nlm.nih.gov/pubmed/29161348">PubMed Abstract </a> | <a target=xrefwindow id=d92168e985 href="https://doi.org/10.1093/annonc/mdx740">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734327975"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e994 class=n-a></a>Lester-Coll NH, Dosoretz AP, Hayman JA, <i> et al.</i>: Health State Utilities for Patients with Brain Metastases. <i>Cureus.</i> 2016; <b>8</b>(7): e667. <a target=xrefwindow id=d92168e1005 href="http://www.ncbi.nlm.nih.gov/pubmed/27551647">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1008 href="https://doi.org/10.7759/cureus.667">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4977223">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734327975">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d92168e1025 class=n-a></a>Gondi V, Pugh SL, Tome WA, <i> et al.</i>: Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. <i>J Clin Oncol.</i> 2014; <b>32</b>(34): 3810–6. <a target=xrefwindow id=d92168e1036 href="http://www.ncbi.nlm.nih.gov/pubmed/25349290">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1039 href="https://doi.org/10.1200/JCO.2014.57.2909">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4239303">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734327977"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1052 class=n-a></a>Sul J, Kluetz PG, Papadopoulos EJ, <i> et al.</i>: Clinical outcome assessments in neuro-oncology: A regulatory perspective: Table 1. <i>Neuro Oncol Pract.</i> 2016; <b>3</b>(1): 4–9. <a target=xrefwindow id=d92168e1063 href="https://doi.org/10.1093/nop/npv062">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734327977">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d92168e1076 class=n-a></a>DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. <i>Neurology.</i> 1989; <b>39</b>(6): 789–96. <a target=xrefwindow id=d92168e1084 href="http://www.ncbi.nlm.nih.gov/pubmed/2725874">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1087 href="https://doi.org/10.1212/WNL.39.6.789">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d92168e1096 class=n-a></a>Chen HS, Pellegrini JW, Aggarwal SK, <i> et al.</i>: Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. <i>J Neurosci.</i> 1992; <b>12</b>(11): 4427–36. <a target=xrefwindow id=d92168e1107 href="http://www.ncbi.nlm.nih.gov/pubmed/1432103">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1110 href="https://doi.org/10.1523/JNEUROSCI.12-11-04427.1992 ">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d92168e1120 class=n-a></a>Chen HS, Lipton SA: Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: Uncompetitive antagonism. <i>J Physiol (Lond).</i> 1997; <b>499</b>(Pt 1): 27–46. <a target=xrefwindow id=d92168e1128 href="http://www.ncbi.nlm.nih.gov/pubmed/9061638">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1131 href="https://doi.org/10.1113/jphysiol.1997.sp021909">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1134 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1159335">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d92168e1143 class=n-a></a>Orgogozo JM, Rigaud AS, Stöffler A, <i> et al.</i>: Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). <i>Stroke.</i> 2002; <b>33</b>(7): 1834–9. <a target=xrefwindow id=d92168e1154 href="http://www.ncbi.nlm.nih.gov/pubmed/12105362">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1157 href="https://doi.org/10.1161/01.STR.0000020094.08790.49">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d92168e1166 class=n-a></a>Wilcock G, Möbius HJ, Stöffler A: A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). <i>Int Clin Psychopharmacol.</i> 2002; <b>17</b>(6): 297–305. <a target=xrefwindow id=d92168e1174 href="http://www.ncbi.nlm.nih.gov/pubmed/12409683">PubMed Abstract </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d92168e1183 class=n-a></a>Brown PD, Pugh S, Laack NN, <i> et al.</i>: Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. <i>Neuro Oncol.</i> 2013; <b>15</b>(10): 1429–37. <a target=xrefwindow id=d92168e1194 href="http://www.ncbi.nlm.nih.gov/pubmed/23956241">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1197 href="https://doi.org/10.1093/neuonc/not114">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3779047">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d92168e1210 class=n-a></a>Eriksson PS, Perfilieva E, Björk-Eriksson T, <i> et al.</i>: Neurogenesis in the adult human hippocampus. <i>Nat Med.</i> 1998; <b>4</b>(11): 1313–7. <a target=xrefwindow id=d92168e1221 href="http://www.ncbi.nlm.nih.gov/pubmed/9809557">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1224 href="https://doi.org/10.1038/3305">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d92168e1233 class=n-a></a>Monje ML, Mizumatsu S, Fike JR, Palmer TD, <i> et al.</i>: Irradiation induces neural precursor-cell dysfunction. <i>Nat Med.</i> 2002; <b>8</b>(9): 955–62. <a target=xrefwindow id=d92168e1244 href="http://www.ncbi.nlm.nih.gov/pubmed/12161748">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1247 href="https://doi.org/10.1038/nm749">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d92168e1257 class=n-a></a>Eichler AF, Chung E, Kodack DP, <i> et al.</i>: The biology of brain metastases-translation to new therapies. <i>Nat Rev Clin Oncol.</i> 2011; <b>8</b>(6): 344–56. <a target=xrefwindow id=d92168e1268 href="http://www.ncbi.nlm.nih.gov/pubmed/21487419">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1271 href="https://doi.org/10.1038/nrclinonc.2011.58">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1275 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3259742">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d92168e1284 class=n-a></a>Fortin D: The blood-brain barrier: its influence in the treatment of brain tumors metastases. <i>Curr Cancer Drug Targets.</i> 2012; <b>12</b>(3): 247–59. <a target=xrefwindow id=d92168e1292 href="http://www.ncbi.nlm.nih.gov/pubmed/22229251">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1295 href="https://doi.org/10.2174/156800912799277511">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717976512"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1304 class=n-a></a>Welsh JW, Komaki R, Amini A, <i> et al.</i>: Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. <i>J Clin Oncol.</i> 2013; <b>31</b>(7): 895–902. <a target=xrefwindow id=d92168e1315 href="http://www.ncbi.nlm.nih.gov/pubmed/23341526">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1318 href="https://doi.org/10.1200/JCO.2011.40.1174">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1322 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3577951">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717976512">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d92168e1335 class=n-a></a>Ceresoli GL, Cappuzzo F, Gregorc V, <i> et al.</i>: Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. <i>Ann Oncol.</i> 2004; <b>15</b>(7): 1042–7. <a target=xrefwindow id=d92168e1346 href="http://www.ncbi.nlm.nih.gov/pubmed/15205197">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1349 href="https://doi.org/10.1093/annonc/mdh276">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727072323"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1358 class=n-a></a>Mok TS, Wu YL, Ahn MJ, <i> et al.</i>: Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer. <i>N Engl J Med.</i> 2017; <b>376</b>(7): 629–40. <a target=xrefwindow id=d92168e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/27959700">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1372 href="https://doi.org/10.1056/NEJMoa1612674">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727072323">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d92168e1385 class=n-a></a>Ahn M, Tsai CM, Yang JC, <i> et al.</i>: AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: data from phase II studies. <i>Eur J Cancer.</i> 2015; <b>51</b>(Supplement 3): S625–6. <a target=xrefwindow id=d92168e1396 href="https://doi.org/10.1016/S0959-8049(16)31724-5">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733715269"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1406 class=n-a></a>Wu YL, Ahn MJ, Garassino MC, <i> et al.</i>: CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3). <i>J Clin Oncol.</i> 2018; <b>36</b>(26): 2702–9. <a target=xrefwindow id=d92168e1417 href="http://www.ncbi.nlm.nih.gov/pubmed/30059262">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1420 href="https://doi.org/10.1200/JCO.2018.77.9363">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733715269">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d92168e1433 class=n-a></a>Ahn MJ, Kim DW, Cho BC, <i> et al.</i>: Phase I study (BLOOM) of AZD3759, a BBB penetrable EGFR inhibitor, in patients with TKI-naïve, EGFRm NSCLC with CNS metastases. | 2017 ASCO Annual Meeting Abstracts. <i>J Clin Oncol.</i> 2017; <b>35</b>(suppl 5): 2006. <a target=xrefwindow id=d92168e1444 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.2006">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d92168e1453 class=n-a></a>Cho BC, Ahn MJ, Lee JS, <i> et al.</i>: Phase I study (BLOOM) of AZD3759, a BBB penetrable EGFR inhibitor, in EGFRm NSCLC patients with leptomeningeal metastasis (LM) who progressed after other anti-cancer therapy. <i>J Clin Oncol.</i> 2017; <b>35</b>(suppl 5): 2069. <a target=xrefwindow id=d92168e1464 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.2069">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d92168e1473 class=n-a></a>Wang H, Zhang L, Zheng X, <i> et al.</i>: The ability of avitinib to penetrate the blood brain barrier and its control of intra-/extra- cranial disease in patients of non-small cell lung cancer (NSCLC) harboring EGFR T790M mutation. <i>J Clin Oncol.</i> 2017; <b>35</b>(suppl 5). <a target=xrefwindow id=d92168e1484 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.e20613">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727291392"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1493 class=n-a></a>Economopoulou P, Mountzios G: Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy. <i>Transl Lung Cancer Res.</i> 2016; <b>5</b>(6): 588–98. <a target=xrefwindow id=d92168e1501 href="http://www.ncbi.nlm.nih.gov/pubmed/28149754">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1504 href="https://doi.org/10.21037/tlcr.2016.12.06">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1507 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5233883">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727291392">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994248"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1520 class=n-a></a>Gadgeel SM, Shaw AT, Govindan R, <i> et al.</i>: Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With <i>ALK</i>-Positive Non-Small-Cell Lung Cancer. <i>J Clin Oncol.</i> 2016; <b>34</b>(34): 4079–85. <a target=xrefwindow id=d92168e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/27863201">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1538 href="https://doi.org/10.1200/JCO.2016.68.4639">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994248">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726559764"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1552 class=n-a></a>Crinò L, Ahn MJ, De Marinis F, <i> et al.</i>: Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With <i>ALK</i>-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2. <i>J Clin Oncol.</i> 2016; <b>34</b>(24): 2866–73. <a target=xrefwindow id=d92168e1566 href="http://www.ncbi.nlm.nih.gov/pubmed/27432917">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1570 href="https://doi.org/10.1200/JCO.2015.65.5936">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726559764">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d92168e1583 class=n-a></a>Gettinger S, Kim D, Tiseo M: Brigatinib activity in patients with ALK+ NSCLC and intracranial CNS metastases in two clinical trials. <i>International Association for the Study of Lung Cancer 17th World Conference on Lung Cancer</i>. Vienna, Austria; 2016. <a target=xrefwindow id=d92168e1588 href="http://phx.corporate-ir.net/External.File%3Fitem%3DUGFyZW50SUQ9MzYwMDg1fENoaWxkSUQ9LTF8VHlwZT0z%26t%3D1%26cb%3D636165372114628196">Reference Source</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734065835"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1597 class=n-a></a>Camidge DR, Kim HR, Ahn MJ, <i> et al.</i>: Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer. <i>N Engl J Med.</i> 2018. <a target=xrefwindow id=d92168e1605 href="http://www.ncbi.nlm.nih.gov/pubmed/30280657">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1608 href="https://doi.org/10.1056/NEJMoa1810171">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734065835">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d92168e1621 class=n-a></a>Venur VA, Ahluwalia MS: Targeted Therapy in Brain Metastases: Ready for Primetime? <i>Am Soc Clin Oncol Educ Book.</i> 2016; <b>35</b>: e123–30. <a target=xrefwindow id=d92168e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/27249714">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1632 href="https://doi.org/10.1200/EDBK_100006">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726760512"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1641 class=n-a></a>Venur VA, Leone JP: Targeted Therapies for Brain Metastases from Breast Cancer. <i>Int J Mol Sci.</i> 2016; <b>17</b>(9): pii: E1543. <a target=xrefwindow id=d92168e1649 href="http://www.ncbi.nlm.nih.gov/pubmed/27649142">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1652 href="https://doi.org/10.3390/ijms17091543">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5037817">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726760512">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724195112"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1668 class=n-a></a>Lin NU, Diéras V, Paul D, <i> et al.</i>: Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. <i>Clin Cancer Res.</i> 2009; <b>15</b>(4): 1452–9. <a target=xrefwindow id=d92168e1679 href="http://www.ncbi.nlm.nih.gov/pubmed/19228746">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1682 href="https://doi.org/10.1158/1078-0432.CCR-08-1080">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724195112">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d92168e1696 class=n-a></a>Lin NU, Carey LA, Liu MC, <i> et al.</i>: Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. <i>J Clin Oncol.</i> 2008; <b>26</b>(12): 1993–9. <a target=xrefwindow id=d92168e1707 href="http://www.ncbi.nlm.nih.gov/pubmed/18421051">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1710 href="https://doi.org/10.1200/JCO.2007.12.3588">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1714 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4524351">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717964598"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1723 class=n-a></a>Bachelot T, Romieu G, Campone M, <i> et al.</i>: Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. <i>Lancet Oncol.</i> 2013; <b>14</b>(1): 64–71. <a target=xrefwindow id=d92168e1734 href="http://www.ncbi.nlm.nih.gov/pubmed/23122784">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1737 href="https://doi.org/10.1016/S1470-2045(12)70432-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717964598">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726113440"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1750 class=n-a></a>Freedman RA, Gelman RS, Wefel JS, <i> et al.</i>: Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. <i>J Clin Oncol.</i> 2016; <b>34</b>(9): 945–52. <a target=xrefwindow id=d92168e1761 href="http://www.ncbi.nlm.nih.gov/pubmed/26834058">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1764 href="https://doi.org/10.1200/JCO.2015.63.0343">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1768 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5070554">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726113440">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d92168e1781 class=n-a></a>Freedman R, Gelman R, Melisko M, <i> et al.</i>: TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM). <i>J Clin Oncol.</i> 2017; <b>35</b>(15_suppl): 1005. <a target=xrefwindow id=d92168e1792 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.1005">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d92168e1801 class=n-a></a>Borges VF, Ferrario C, Aucoin N, <i> et al.</i>: Efficacy results of a phase 1b study of ONT-380, a CNS-penetrant TKI, in combination with T-DM1 in HER2+ metastatic breast cancer (MBC), including patients (pts) with brain metastases. <i>J Clin Oncol.</i> ASCO Meeting Abstracts, 2016; <b>34</b>(15_suppl): 513. <a target=xrefwindow id=d92168e1812 href="https://doi.org/10.1200/JCO.2016.34.15_suppl.513">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d92168e1821 class=n-a></a>Lin NU, Freedman RA, Miller K, <i> et al.</i>: Determination of the maximum tolerated dose (MTD) of the CNS penetrant tyrosine kinase inhibitor (TKI) tesevatinib administered in combination with trastuzumab in HER2+ patients with metastatic breast cancer (BC). <i>J Clin Oncol.</i> ASCO Meeting Abstracts 2016; <b>34</b>(15_suppl): 514. <a target=xrefwindow id=d92168e1832 href="https://doi.org/10.1200/JCO.2016.34.15_suppl.514">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727127866"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1842 class=n-a></a>McArthur GA, Maio M, Arance A, <i> et al.</i>: Vemurafenib in metastatic melanoma patients with brain metastases: An open-label, single-arm, phase 2, multicentre study. <i>Ann Oncol.</i> 2017; <b>28</b>(3): 634–41. <a target=xrefwindow id=d92168e1853 href="http://www.ncbi.nlm.nih.gov/pubmed/27993793">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1856 href="https://doi.org/10.1093/annonc/mdw641">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727127866">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962072"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1869 class=n-a></a>Long GV, Trefzer U, Davies MA, <i> et al.</i>: Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. <i>Lancet Oncol.</i> 2012; <b>13</b>(11): 1087–95. <a target=xrefwindow id=d92168e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/23051966">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1883 href="https://doi.org/10.1016/S1470-2045(12)70431-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962072">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727696033"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1896 class=n-a></a>Davies MA, Saiag P, Robert C, <i> et al.</i>: Dabrafenib plus trametinib in patients with <i>BRAF</i><sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): A multicentre, multicohort, open-label, phase 2 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(7): 863–73. <a target=xrefwindow id=d92168e1912 href="http://www.ncbi.nlm.nih.gov/pubmed/28592387">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1916 href="https://doi.org/10.1016/S1470-2045(17)30429-1">Publisher Full Text </a> | <a target=xrefwindow id=d92168e1919 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5991615">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727696033">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d92168e1932 class=n-a></a>Berghoff AS, Venur VA, Preusser M, <i> et al.</i>: Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment. <i>Am Soc Clin Oncol Educ Book.</i> 2016; <b>35</b>: e116–22. <a target=xrefwindow id=d92168e1943 href="http://www.ncbi.nlm.nih.gov/pubmed/27249713">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1946 href="https://doi.org/10.1200/EDBK_100005">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720488787"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1955 class=n-a></a>Margolin K, Ernstoff MS, Hamid O, <i> et al.</i>: Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial. <i>Lancet Oncol.</i> 2012; <b>13</b>(5): 459–65. <a target=xrefwindow id=d92168e1966 href="http://www.ncbi.nlm.nih.gov/pubmed/22456429">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1969 href="https://doi.org/10.1016/S1470-2045(12)70090-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720488787">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726401484"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e1982 class=n-a></a>Goldberg SB, Gettinger SN, Mahajan A, <i> et al.</i>: Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. <i>Lancet Oncol.</i> 2016; <b>17</b>(7): 976–83. <a target=xrefwindow id=d92168e1993 href="http://www.ncbi.nlm.nih.gov/pubmed/27267608">PubMed Abstract </a> | <a target=xrefwindow id=d92168e1996 href="https://doi.org/10.1016/S1470-2045(16)30053-5">Publisher Full Text </a> | <a target=xrefwindow id=d92168e2000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5526047">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726401484">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d92168e2014 class=n-a></a>Tawbi H, Forsyth P, Algazi A, <i> et al.</i>: Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204. <i>J Clin Oncol.</i> 2017; <b>35</b>(15_suppl): 9507. <a target=xrefwindow id=d92168e2025 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.9507">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d92168e2034 class=n-a></a>Long G, Atkinson V, Menzies A, <i> et al.</i>: A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC). <i>J Clin Oncol.</i> 2017; <b>35</b>(15_suppl): 9508. <a target=xrefwindow id=d92168e2045 href="https://doi.org/10.1200/JCO.2017.35.15_suppl.9508">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733849152"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2054 class=n-a></a>Tawbi HA, Forsyth PA, Algazi A, <i> et al.</i>: Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain. <i>N Engl J Med.</i> 2018; <b>379</b>(8): 722–30. <a target=xrefwindow id=d92168e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/30134131">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2068 href="https://doi.org/10.1056/NEJMoa1805453">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733849152">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d92168e2081 class=n-a></a>Kotecha R, Miller JA, Venur VA, <i> et al.</i>: Melanoma brain metastasis: the impact of stereotactic radiosurgery, <i>BRAF</i> mutational status, and targeted and/or immune-based therapies on treatment outcome. <i>J Neurosurg.</i> 2018; <b>129</b>(1): 50–9. <a target=xrefwindow id=d92168e2095 href="http://www.ncbi.nlm.nih.gov/pubmed/28799876">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2099 href="https://doi.org/10.3171/2017.1.JNS162797">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725290626"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2108 class=n-a></a>Lim SH, Lee JY, Lee MY, <i> et al.</i>: A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. <i>Ann Oncol.</i> 2015; <b>26</b>(4): 762–8. <a target=xrefwindow id=d92168e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/25538174">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2122 href="https://doi.org/10.1093/annonc/mdu584">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725290626">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733847671"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2135 class=n-a></a>Xie L, Nagpal S, Wakelee HA, <i> et al.</i>: Osimertinib for <i>EGFR</i>-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study. <i>Oncologist.</i> 2018; pii: theoncologist.2018-0264. <a target=xrefwindow id=d92168e2146 href="http://www.ncbi.nlm.nih.gov/pubmed/30126856">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2149 href="https://doi.org/10.1634/theoncologist.2018-0264">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733847671">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d92168e2163 class=n-a></a>Magnuson WJ, Lester-Coll NH, Wu AJ, <i> et al.</i>: Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. <i>J Clin Oncol.</i> 2017; <b>35</b>(10): 1070–7. <a target=xrefwindow id=d92168e2174 href="http://www.ncbi.nlm.nih.gov/pubmed/28113019">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2177 href="https://doi.org/10.1200/JCO.2016.69.7144">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5610957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2186 class=n-a></a>Ding L, Ellis MJ, Li S, <i> et al.</i>: Genome remodelling in a basal-like breast cancer metastasis and xenograft. <i>Nature.</i> 2010; <b>464</b>(7291): 999–1005. <a target=xrefwindow id=d92168e2197 href="http://www.ncbi.nlm.nih.gov/pubmed/20393555">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2200 href="https://doi.org/10.1038/nature08989">Publisher Full Text </a> | <a target=xrefwindow id=d92168e2204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2872544">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5610957">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725812637"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2217 class=n-a></a>Brastianos PK, Carter SL, Santagata S, <i> et al.</i>: Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. <i>Cancer Discov.</i> 2015; <b>5</b>(11): 1164–77. <a target=xrefwindow id=d92168e2228 href="http://www.ncbi.nlm.nih.gov/pubmed/26410082">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2231 href="https://doi.org/10.1158/2159-8290.CD-15-0369">Publisher Full Text </a> | <a target=xrefwindow id=d92168e2235 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4916970">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725812637">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d92168e2248 class=n-a></a>Chen G, Chakravarti N, Aardalen K, <i> et al.</i>: Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. <i>Clin Cancer Res.</i> 2014; <b>20</b>(21): 5537–46. <a target=xrefwindow id=d92168e2259 href="http://www.ncbi.nlm.nih.gov/pubmed/24803579">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2262 href="https://doi.org/10.1158/1078-0432.CCR-13-3003">Publisher Full Text </a> | <a target=xrefwindow id=d92168e2266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4216765">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725458457"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d92168e2275 class=n-a></a>Paik PK, Shen R, Won H, <i> et al.</i>: Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. <i>Cancer Discov.</i> 2015; <b>5</b>(6): 610–21. <a target=xrefwindow id=d92168e2286 href="http://www.ncbi.nlm.nih.gov/pubmed/25929848">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2289 href="https://doi.org/10.1158/2159-8290.CD-14-1129">Publisher Full Text </a> | <a target=xrefwindow id=d92168e2293 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4643059">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725458457">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d92168e2306 class=n-a></a>Hohensee I, Lamszus K, Riethdorf S, <i> et al.</i>: Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases. <i>Am J Pathol.</i> 2013; <b>183</b>(1): 83–95. <a target=xrefwindow id=d92168e2317 href="http://www.ncbi.nlm.nih.gov/pubmed/23665199">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2320 href="https://doi.org/10.1016/j.ajpath.2013.03.023">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d92168e2330 class=n-a></a>Preusser M, Berghoff AS, Berger W, <i> et al.</i>: High rate of <i>FGFR1</i> amplifications in brain metastases of squamous and non-squamous lung cancer. <i>Lung Cancer.</i> 2014; <b>83</b>(1): 83–9. <a target=xrefwindow id=d92168e2344 href="http://www.ncbi.nlm.nih.gov/pubmed/24183471">PubMed Abstract </a> | <a target=xrefwindow id=d92168e2348 href="https://doi.org/10.1016/j.lungcan.2013.10.004">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 09 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1772/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1772/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA<br/> <sup>2</sup> Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA<br/> <sup>3</sup> Northwestern Medicine Cancer Center Warrenville, Warrenville, IL, USA<br/> <sup>4</sup> Northwestern University Feinberg School of Medicine, Chicago, IL, USA<br/> <sup>5</sup> Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA<br/> <sup>6</sup> Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA<br/> <sup>7</sup> Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA<br/> <sup>8</sup> Harvard Medical School, Boston, MA, USA<br/> <p> <div class=margin-bottom> Rupesh Kotecha <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Vinai Gondi <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Manmeet S Ahluwalia <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Priscilla K Brastianos <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Minesh P Mehta <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1772/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 09 Nov 2018, 7:1772 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.15903.1">https://doi.org/10.12688/f1000research.15903.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Kotecha R <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17362 data-id=15903 data-downloads="" data-views="" data-scholar="10.12688/f1000research.15903.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1772/v1/pdf?article_uuid=34777412-2e6a-4922-bda0-d4273962298d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.15903.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Kotecha R, Gondi V, Ahluwalia MS <em>et al.</em> Recent advances in managing brain metastasis [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1772 (<a href="https://doi.org/10.12688/f1000research.15903.1" target=_blank>https://doi.org/10.12688/f1000research.15903.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=15903 id=mobile-track-article-signin-15903 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/15903?target=/articles/7-1772/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17362 /> <input name=articleId type=hidden value=15903 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Seema Nagpal</strong>, Department of Neurology, Stanford University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Eric L Chang</strong>, Department of Radiation Oncology, Keck School of Medicine of the University of Southern California, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 09 Nov 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1772/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1772/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41291-40180></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=41290-40181></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1772/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>09 Nov 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Seema Nagpal</strong>, Department of Neurology, Stanford University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Eric L Chang</strong>, Department of Radiation Oncology, Keck School of Medicine of the University of Southern California, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1772/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1772/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in managing brain metastasis".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1772/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1772/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1772/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Kotecha R et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1772/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1772",
            templates : {
                twitter : "Recent advances in managing brain metastasis. Kotecha R et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1772/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in managing brain metastasis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in managing brain metastasis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/15903/17362")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17362");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "40180": 0,
                           "40181": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "0987ea12-3d04-4a33-b367-a5b682ad1442";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1772.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1772.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1772.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1772.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1772.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>